Company Search:
Advanced Search
Sponsored Links
Aryx Therapeutics, Incorporation Company Snapshot
Aryx Therapeutics, Incorporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aryx Therapeutics, Incorporation with three other companies in this sector in UNITED STATES : Catalyst Biosciences Inc (2008 sales of $20.09 million of which 100% was Biopharmaceutical Products), ProPhase Labs Inc ($20.51 million of which 89% was Cold Remedy Products), and Aveo Pharmaceuticals, Incorporation. ($19.66 million of which 100% was Cancer Therapeutics).

Sales Analysis.
  Stock Performance Chart for Aryx Therapeutics, Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): .02
(Figures in U.S. Dollars)
1 Week 39.1%   13 Weeks 23.3%  
4 Weeks 32.1%   52 Weeks 927.8%  
Aryx Therapeutics, Incorporation Key Data:
  Ticker: ARYX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2008 Sales 19,724,000
(Year Ending Jan 2009).
Employees: 56
  Currency: U.S. Dollars Market Cap: 619,047
  Fiscal Yr Ends: December Shares Outstanding: 33,461,975
  Share Type: Common Closely Held Shares: 17,742,396
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.